West Kazakhstan Medical Journal

Published date: Mar 25 2025

Journal Title: West Kazakhstan Medical Journal

Issue title: West Kazakhstan Medical Journal: Volume 67 Issue 1

Pages: 86 - 98

DOI: 10.18502/wkmj.v67i1.16891

Geetha Bhavani ThotaPreeti.geetha@gmail.comDepartment of Anesthesiology, Bhargav Kidney Care & Multi Specialty Hospital, Vijayawada, Andhra Pradesh

Munagapati Sindhurasindhura.munagapati@gmail.comDepartment of Anesthesiology, ESIC Medical College & Hospital, Hyderabad, Telangana

Sunanda GootyDepartment of Anesthesiology, ESIC Medical College & Hospital, Hyderabad, Telangana

Melatonin, a hormone synthesized by the pineal gland has been demonstrated to promote anesthetic effect when co-administered with propofol. This led to examining the possible role of melatonin in the field of anesthesia, prompting further investigation of its use as an anesthetic adjuvant. In this study, we evaluated the minimal dose of propofol required for anesthetic induction following pre-medication with melatonin in perioperative patients. A clinical study was conducted on 60 patients, aged between 18 and 60 years who were enrolled for various surgical requirements at a tertiary care hospital, in South India. Enrolled patients were divided into two groups and designated as control (without melatonin) and treatment (with melatonin). A 3 mg/Kg melatonin tablet was administered to the melatonin group followed by a pre-determined dose of propofol intravenously, whereas the control group received B-complex followed by propofol. The results indicate administration of melatonin 3 mg as a premedication before the surgery significantly reduced the required dose of the anesthetic drug propofol when compared to the control group. Therefore, supplementation of 3 mg oral melatonin proved to be an effective premedication, offering potential benefits in both sedation and as an adjunct to the commonly used anesthetic induction agent propofol. This study provided initial evidence suggesting that pre-medication with melatonin may influence the dose of propofol required for induction. The observed reduction in propofol dose in the melatonin group has potential implications for optimizing anesthesia induction, potentially contributing to improved patient safety and resource utilization.

Keywords: anesthesia, induction, melatonin, premedication, propofol, anxiety

[1] Hidalgo MP, Auzani JA, Rumpel LC, Moreira NL Jr, Cursino AW, Caumo W. The clinical effect of small oral clonidine doses on perioperative outcomes in patients undergoing abdominal hysterectomy. Anesth Analg. 2005 Mar;100(3):795–802.

[2] Weinbroum AA, Szold O, Ogorek D, Flaishon R. The midazolam-induced paradox phenomenon is reversible by flumazenil. Epidemiology, patient characteristics and review of the literature. Eur J Anaesthesiol. 2001 Dec;18(12):789–97.

[3] Andersen LP, Rosenberg J, Gogenur I. Perioperative melatonin: not ready for prime time. Br J Anaesth. 2014;112(1):7-8.

[4] Su H, Eleveld DJ, Struys MM, Colin PJ. Mechanism-based pharmacodynamic model for propofol haemodynamic effects in healthy volunteers☆. Br J Anaesth. 2022 May;128(5):806–16.

[5] Yousaf F, Seet E, Venkatraghavan L, Abrishami A, Chung F. Efficacy and safety of melatonin as an anxiolytic and analgesic in the perioperative period: a qualitative systematic review of randomized trials. Anesthesiology. 2010 Oct;113(4):968–76.

[6] Borazan H, Tuncer S, Yalcin N, Erol A, Otelcioglu S. Effects of preoperative oral melatonin medication on postoperative analgesia, sleep quality, and sedation in patients undergoing elective prostatectomy: a randomized clinical trial. J Anesth. 2010 Apr;24(2):155–60.

[7] Caumo W, Levandovski R, Hidalgo MP. Preoperative anxiolytic effect of melatonin and clonidine on postoperative pain and morphine consumption in patients undergoing abdominal hysterectomy: a double-blind, randomized, placebo-controlled study. J Pain. 2009 Jan;10(1):100–8.

[8] Ismail SA, Mowafi HA. Melatonin provides anxiolysis, enhances analgesia, decreases intraocular pressure, and promotes better operating conditions during cataract surgery under topical anesthesia. Anesth Analg. 2009 Apr;108(4):1146–51.

[9] Niggemann JR, Tichy A, Eberspächer-Schweda MC, Eberspächer-Schweda E. Preoperative calming effect of melatonin and its influence on propofol dose for anesthesia induction in healthy dogs. Vet Anaesth Analg. 2019 Sep;46(5):560–7.

[10] Kumar R, Kumari K, Janweja S, Kumar R, Verma M, Sharma A, et al. Role of melatonin in attenuation of hemodynamic response to intubation and anesthetic requirements: a randomized, controlled, double-blind study. Braz J Anesthesiol. 2023;73(4):434–40.

[11] Jain N, Tiwari T, Kohli M, Chandra G, Bhatia VK. Effect of oral melatonin on patients’ anxiety scores and dose requirement of propofol during bispectral index-guided induction of general anesthesia. The Indian Anaesthetists Forum. 2019;20(1),16.

[12] Malhotra S, Sawhney G, Pandhi P. The therapeutic potential of melatonin: a review of the science. MedGenMed. 2004 Apr;6(2):46.

[13] Naguib M, Samarkandi AH, Moniem MA, Mansour ED, Alshaer AA, Al-Ayyaf HA, et al. The effects of melatonin premedication on propofol and thiopental induction dose-response curves: a prospective, randomized, doubleblind study. Anesth Analg. 2006 Dec;103(6):1448–52.

[14] Turkistani A, Abdullah KM, Al-Shaer AA, Mazen KF, Alkatheri K. Melatonin premedication and the induction dose of propofol. Eur J Anaesthesiol. 2007 May;24(5):399–402.

[15] Morgan DW, Legge K. Clinical evaluation of propofol as an intravenous anaesthetic agent in cats and dogs. Vet Rec. 1989 Jan;124(2):31–3.

[16] Muir WW 3rd, Gadawski JE. Respiratory depression and apnea induced by propofol in dogs. Am J Vet Res. 1998 Feb;59(2):157–61.

[17] Murison PJ. Effect of propofol at two injection rates or thiopentone on post-intubation apnoea in the dog. J Small Anim Pract. 2001 Feb;42(2):71–4.

[18] Watkins SB, Hall LW, Clarke KW. Propofol as an intravenous anaesthetic agent in dogs. Vet Rec. 1987 Apr;120(14):326–9.

[19] Barchas J, DaCosta F, Spector S. Acute pharmacology of melatonin. Nature. 1967 May;214(5091):919–20.

[20] Bayir A, Kireşi DA, Kara H, Cengiz SL, Koçak S, Ozdinç S, et al. The effects of mannitol and melatonin on MRI findings in an animal model of traumatic brain edema. Acta Neurol Belg. 2008 Dec;108(4):149–54.

[21] Aronson L. Animal behavior case of the month. A dog was evaluated because of extreme fear. J Am Vet Med Assoc. 1999 Jul;215(1):22–4.

[22] Golombek DA, Pévet P, Cardinali DP. Melatonin effects on behavior: possible mediation by the central GABAergic system. Neurosci Biobehav Rev. 1996;20(3):403–12.

[23] Muñoz-Hoyos A, Sánchez-Forte M, Molina-Carballo A, Escames G, Martin-Medina E, Reiter RJ, et al. Melatonin’s role as an anticonvulsant and neuronal protector: experimental and clinical evidence. J Child Neurol. 1998 Oct;13(10):501–9.

[24] Molina-Carballo A, Muñoz-Hoyos A, Sánchez-Forte M, Uberos-Fernández J, Moreno-Madrid F, Acuña-Castroviejo D. Melatonin increases following convulsive seizures may be related to its anticonvulsant properties at physiological concentrations. Neuropediatrics. 2007 Jun;38(3):122–5.

[25] Solmaz I, Gürkanlar D, Gökçil Z, Göksoy C, Ozkan M, Erdoğan E. Antiepileptic activity of melatonin in guinea pigs with pentylenetetrazol-induced seizures. Neurol Res. 2009 Nov;31(9):989–95.

[26] Cardinali DP, Pandi-Perumal SR, Niles LP. Melatonin and its receptors: biological function in circadian sleepwake regulation. In: Monti JM, Pandi-Perumal SR, Sinton CM, editors. Neurochemistry of Sleep and Wakefulness. Cambridge, UK: Cambridge University Press; 2008. pp. 283–314.

[27] Shavali S, Ho B, Govitrapong P, Sawlom S, Ajjimaporn A, Klongpanichapak S, et al. Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of β-endorphin an endogenous opioid. Brain Res Bull. 2005 Jan;64(6):471–9.

[28] Srinivasan V, Lauterbach EC, Ho KY, Acuña-Castroviejo D, Zakaria R, Brzezinski A. Melatonin in antinociception: its therapeutic applications. Curr Neuropharmacol. 2012 Jun;10(2):167–78.

[29] Lakin ML, Miller CH, Stott ML, Winters WD. Involvement of the pineal gland and melatonin in murine analgesia. Life Sci. 1981 Dec;29(24):2543–51.

[30] Odagaki Y, Nishi N, Koyama T. Functional coupling of GABA(B) receptors with G proteins that are sensitive to N-ethylmaleimide treatment, suramin, and benzalkonium chloride in rat cerebral cortical membranes. J Neural Transm (Vienna). 2000;107(10):1101–16.

[31] Patel S, Naeem S, Kesingland A, Froestl W, Capogna M, Urban L, et al. The effects of GABA(B) agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat. Pain. 2001 Feb;90(3):217–26.

[32] Wilhelmsen M, Amirian I, Reiter RJ, Rosenberg J, Gögenur I. Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies. J Pineal Res. 2011 Oct;51(3):270–7.

[33] Sahinovic MM, Struys MM, Absalom AR. Clinical pharmacokinetics and pharmacodynamics of propofol. Clin Pharmacokinet. 2018 Dec;57(12):1539–58.

[34] Valanne J, Korttila K. Comparison of methohexitone and propofol (‘Diprivan’) for induction of enflurane anaesthesia in outpatients. Postgrad Med J. 1985;61 Suppl 3:138–43.

[35] Veselis RA, Reinsel RA, Feshchenko VA, Wroński M. The comparative amnestic effects of midazolam, propofol, thiopental, and fentanyl at equisedative concentrations. Anesthesiology. 1997 Oct;87(4):749–64.

[36] Zheng D, Upton RN, Martinez AM, Grant C, Ludbrook GL. The influence of the bolus injection rate of propofol on its cardiovascular effects and peak blood concentrations in sheep. Anesth Analg. 1998 May;86(5):1109–15.

[37] Naguib M, Gottumukkala V, Goldstein PA. Melatonin and anesthesia: a clinical perspective. J Pineal Res. 2007 Jan;42(1):12–21.

[38] Benitez-King G, Túnez I, Bellon A, Ortíz GG, Antón-Tay F. Melatonin prevents cytoskeletal alterations and oxidative stress induced by okadaic acid in N1E-115 cells. Exp Neurol. 2003 Jul;182(1):151–9.

[39] Acil M, Basgul E, Celiker V, Karagöz AH, Demir B, Aypar U. Perioperative effects of melatonin and midazolam premedication on sedation, orientation, anxiety scores and psychomotor performance. Eur J Anaesthesiol. 2004 Jul;21(7):553–7.

[40] Andersen LP, Werner MU, Rosenkilde MM, Fenger AQ, Petersen MC, Rosenberg J, et al. Pharmacokinetics of high-dose intravenous melatonin in humans. J Clin Pharmacol. 2016 Mar;56(3):324–9.

[41] Andersen LP, Gögenur I, Rosenberg J, Reiter RJ. The safety of melatonin in humans. Clin Drug Investig. 2016 Mar;36(3):169–75.

[42] Radwan K, Youssef M, El-Tawdy A, Zeidan M, Kamal N. Melatonin versus Gabapentin: a comparative study of preemptive medications. The Int J Anaesthesiol. 2010;23(1).

[43] Fan Y, Yuan L, Ji M, Yang J, Gao D. The effect of melatonin on early postoperative cognitive decline in elderly patients undergoing hip arthroplasty: A randomized controlled trial. J Clin Anesth. 2017 Jun;39:77–81.

[44] Foley HM, Steel AE. Adverse events associated with oral administration of melatonin: A critical systematic review of clinical evidence. Complement Ther Med. 2019 Feb;42:65–81.

[45] Kalam AK, Narmada P, Shyam SA. Oral Melatonin as a Premedication and its Effect on Induction dose of Thiopentone Sodium: A Placebo controlled Study. Ind J Anesth Analgesia. 2018;5(8):1354–60.